Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Cancer Science|June 19, 2010
Efficacy of intraoperative GeneSearch Breast Lymph Node (BLN) Assay for breast cancer metastasis detection in sentinel lymph node in Chinese patientsYan-Hui Liu, Fang-Ping Xu, Ning Liao, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|November 27, 2008
[Clinicopathologic significance of bcl-6 gene rearrangement and expression in three molecular subgroups of diffuse large B-cell lymphoma]Fang-ping Xu, Yan-hui Liu, Xin-lan Luo, et al.
International Journal of Cancer|April 5, 2024
Clinical efficacy of tumor organoid-guided cancer therapy for locally advanced unresectable or metastatic breast cancerYing-Yi Lin, Hong-Fei Gao, Hong Li, et al.
Cancer Letters|August 6, 2010
RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivoYangchao Chen, Dan Xie, Wing Yin Li, et al.
Breast Cancer Research and Treatment|September 2, 2017
Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelinesFang-Ping Xu, Kun Wang, Jie Xu, et al.
Cancer Medicine|October 27, 2016
Overexpression of SRC-3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasivenessFang-Ping Xu, Yan-Hui Liu, Xin-Lan Luo, et al.
Human Pathology|April 29, 2008
Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patientsYan-Hui Liu, Fang-Ping Xu, Heng-Guo Zhuang, et al.
Diagnostic Pathology|September 20, 2013
Immunophenotypic features and t(14;18) (q32;q21) translocation of Chinese follicular lymphomas helps to distinguish subgroupsFen Zhang, Li-Xu Yan, Su-Xia Lin, et al.
Lung Cancer (Amsterdam, Netherlands)|September 23, 2015
Rare discrepancies in a driver gene alteration within histologically heterogeneous primary lung cancersWen-zhao Zhong, Jian Su, Fang-ping Xu, et al.
International Journal of Oncology|December 18, 2015
PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancerLi-Xu Yan, Yan-Hui Liu, Jian-Wen Xiang, et al.
Pageof 4